Effect of DFM on Quadriceps Spasticity in Stroke Patients (NCT07537322) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Effect of DFM on Quadriceps Spasticity in Stroke Patients
30 participantsStarted 2026-05-01
Plain-language summary
The goal of this clinical trial is to learn if deep friction massage works to reduce quadriceps muscle spasticity in adults with sub-acute Stroke. It will also learn about the effectiveness of this technique in improving lower limb motor function and mobility.
The main questions it aims to answer are:
* Does deep friction massage reduce quadriceps spasticity in stroke patients as measured by the Modified Ashworth Scale?
* Does deep friction massage improve lower limb motor recovery as measured by the Fugl-Meyer Assessment?
* Does deep friction massage improve functional mobility as measured by the Timed Up and Go Test?
Researchers will compare deep friction massage combined with conventional physiotherapy to conventional physiotherapy alone to see if deep friction massage improves spasticity and functional outcomes in patients with stroke.
Who can participate
Age range
40 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age ≥ 40 years
* Ischemic or hemorrhagic stroke diagnosis.
* Subacute stage (1-6 months after stroke)
* Quadriceps spasticity (Modified Ashworth Scale 1 or above)
* Walking with or without assistive aids.
* Stable health-wise and can be involved in rehabilitation.
Exclusion Criteria:
* The participants were not allowed in case they had:
* Severe mental failure (MMSE score under 24)
* Lower limb musculoskeletal or other neurological disorders.
* Contraindications to massage therapy (e.g. thrombosis, skin infection, fracture)
* Weakened or no spasticity of the quadriceps.
* Extreme medical instability inability to take part.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Spasticity of Quadriceps (by the Modified Ashworth Scale (MAS))